RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Healthcare Product Import-Export Regulations: China, India and South Korea

Healthcare Product Import-Export Regulations: China, India and South Korea

Posted 01 February 2009 | By

In the past 10 years, Asia has burgeoned into one of the fastest-growing markets in the world, not just in gross domestic product and import-export considerations, but also as a source of manpower and knowledge for industry to tap when outsourcing manufacturing, research, design/development and general administrative functions. Indeed, the world is flat, and modern technology and communications have hastened the streamlining of international commerce. In the case of the healthcare industry, Asia is one of the most attractive regions in which to do business, in view of its strong economic growth and sundry demographic factors that have propelled an increase in healthcare spending, high per capita consumption of healthcare products and entrepreneurship.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.